Table 4.
Hemodynamic parameters: systolic blood pressure (SBP) and diastolic blood pressure (DBP) (mm Hg), heart rate (HR) (beats/minute), and oxygen saturation (SpO2, %) (mean, standard deviation)
| Group Ca (n = 52) | Group Nb (n = 48) | P value | |
|---|---|---|---|
| Baseline | |||
| SBP, DBP | 123.8 (17.9, 69.7 (13.7) | 140.5 (25.3), 73.8 (12.4) | 0.098, 0.067 |
| HR, SpO2 | 77.5 (12.4), 99.3 (1.0) | 82.3 (12.2), 99.5 (0.9) | 0.126, 0.196 |
| Scope insertion | |||
| SBP, DBP | 121.1 (17.5), 71.6 (13.0) | 130.2 (24.0), 73.5 (9.4) | 0.013,* 0.046* |
| HR, SpO2 | 78.5 (12.5), 99.6 (0.8) | 81.0 (16.7), 99.5 (1.0) | 0.027,* 0.775 |
| 5 min | |||
| SBP, DBP | 120.3 (20.4), 69.2 (13.6) | 128.4 (23.5), 73.7 (12.9) | 0.011,* 0.019* |
| HR, SpO2 | 79.9 (10.7), 99.5 (0.9) | 83.1 (11.0), 99.5 (1.0) | 0.006,* 0.390 |
| 10 min | |||
| SBP, DBP | 118.9 (17.4), 71.1 (10.9) | 119.3 (19.9), 70.3 (13.9) | 0.052, 0.012* |
| HR, SpO2 | 78.9 (10.5), 99.7 (0.6) | 81.4 (11.1), 99.5 (0.8) | 0.085, 0.670 |
| 15 min | |||
| SBP, DBP | 117.0 (15.9), 72.3 (11.1) | 114.9 (19.5), 69.3 (11.8) | 0.272, 0.008* |
| HR, SpO2 | 81.5 (9.2), 99.7 (0.6) | 82.6 (13.7), 99.4 (0.9) | 0.131, 0.232 |
| 20 min | |||
| SBP, DBP | 122.4 (18.4), 72.4 (13.6) | 116.2 (17.8), 72.3 (12.4) | 0.088, 0.163 |
| HR, SpO2 | 83.0 (8.8), 99.7 (0.6) | 84.53 (11.6), 99.5 (0.8) | 0.001,* 0.565 |
| 25 min | |||
| SBP, DBP | 120.3 (20.2), 72.0 (12.9) | 118.4 (20.4), 69.7 (11.2) | 0.194, 0.091 |
| HR, SpO2 | 82.0 (9.6), 99.7 (0.7) | 84.6 (13.0), 99.6 (0.7) | 0.128, 0.737 |
| 30 min | |||
| SBP, DBP | 115.2 (15.6), 71.9 (11.3) | 116.2 (21.9), 67.5 (12.5) | 0.541, 0.202 |
| HR, SpO2 | 80.6 (10.8), 99.7 (0.7) | 86.7 (14.0), 99.5 (0.9) | 0.089, 0.223 |
| 35 min | |||
| SBP, DBP | 114.5 (14.4), 74.4 (12.2) | 118.2 (17.9), 69.1 (12.6) | 0.254, 0.250 |
| HR, SpO2 | 80.3 (7.5), 99.2 (3.1) | 83.0 (9.7), 99.6 (0.8) | 0.093, 0.150 |
| 40 min | |||
| SBP, DBP | 114.1 (9.9), 71.1 (10.0) | 120.5 (23.1), 72.2 (15.2) | 0.188, 0.161 |
| HR, SpO2 | 81.5 (7.1), 99.9 (0.3) | 86.7 (10.2), 99.6 (0.7) | 0.200, 0.233 |
| 45 min | |||
| SBP, DBP | 119.5 (9.0), 75.5 (8.9) | 115.9 (14.1), 72.1 (10.9) | 0.582, 0.435 |
| HR, SpO2 | 83.3 (3.8), 99.8 (0.4) | 84.8 (8.6), 99.9 (0.4) | 0.248, 0.867 |
| 50 min | |||
| SBP, DBP | 117.3 (5.9), 73.1 (9.4) | 112.4 (17.4), 72.9 (12.0) | 0.441, 0.207 |
| HR, SpO2 | 98.3 (34.5), 99.9 (0.4) | 84.4 (10.1), 99.5 (0.5) | 0.255, 0.171 |
| 55 min | |||
| SBP, DBP | 116.3 (4.7), 77.0 (5.7) | 109.5 (13.5), 68.7 (10.1) | 0.199, 0.292 |
| HR, SpO2 | 80.7 (4.2), 100.0 (0.0) | 86.0 (11.5), 99.5 (0.5) | 0.372, 0.049* |
| 60 min | |||
| SBP, DBP | 123.8 (4.4), 80.8 (2.6) | 104.3 (14.6), 68.0 (14.7) | 0.109, 0.390 |
| HR, SpO2 | 82.4 (4.3), 100 (0.0) | 85.0 (8.3), 99.5 (1.0) | 0.174, 0.236 |
Notes:
a
Group C: clinical assessment;
b
Group N: NarcotrendTM monitoring;
*
Considered to be of statistical significance.